Temporal Pattern of Circulating DNA for Patients Receiving Irradiation
Terminated
- Conditions
- Radiation
- Registration Number
- NCT01099020
- Lead Sponsor
- University of Rochester
- Brief Summary
The purpose of the research study is to test a measurement tool that will determine the radiation dose people receive when they have been accidentally exposed to radiation. This test will be done using a small amount of blood and known dose of radiation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
- Patient must be scheduled to undergo Total Body Irradiation (TBI) as part of a conditioning regime for a Bone Marrow Transplant. OR, Be scheduled to undergo Radiation Therapy treatment for a malignancy or other disease and have a radiation treatment field that contains at least 2 liters of tissue receiving at least 2 Gy radiation dose over the first 5 days of treatment.
- Patient must be willing to have blood draws as defined below.
- Patient must provide study-specific informed consent prior to study entry.
- Hemoglobin≥8.
- Age ≥ 18, but not older than age 60.
Exclusion Criteria
- Patients not meeting the above inclusion criteria.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does circulating cell-free DNA kinetics correlate with radiation biodosimetry in total body irradiation patients?
What molecular mechanisms drive DNA release patterns after accidental radiation exposure in NCT01099020?
Are circulating DNA biomarkers more effective than dicentric chromosome analysis for radiation dose estimation?
What adverse events are associated with total body irradiation and how does circulating DNA monitoring aid management?
How do DNA repair pathway inhibitors like olaparib influence circulating DNA dynamics in radiation exposure scenarios?
Trial Locations
- Locations (1)
University of Rochester
🇺🇸Rochester, New York, United States
University of Rochester🇺🇸Rochester, New York, United States